Small Molecules
Total Trials
15
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,895
NCT04504708
Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 17, 2021
Completion: Jul 8, 2022
NCT05217732
Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers
Phase: Phase 1
Start: Dec 1, 2021
Completion: Dec 19, 2022
NCT05118841
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
Start: Jan 3, 2022
Completion: May 31, 2024
NCT05269940
A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies
Start: Feb 17, 2022
Completion: Jul 5, 2024
NCT05258266
A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors
Start: Mar 9, 2022
Completion: Apr 30, 2024
NCT05702489
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
Phase: Phase 2/3
Start: Jul 17, 2022
Completion: Oct 13, 2023
NCT05720091
Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China
Start: Feb 14, 2023
Completion: Jul 25, 2023
NCT05711797
Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects
Start: Apr 12, 2023
Completion: Aug 9, 2024
NCT05949385
A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China
Start: Jul 2, 2023
Completion: Jan 11, 2024
NCT05955027
A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
Start: Jul 8, 2023
Completion: Dec 15, 2023
NCT06057103
A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects
Start: Aug 28, 2023
Completion: Apr 26, 2024
NCT06099873
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
Phase: Phase 3
Start: Nov 30, 2023
Completion: Feb 13, 2025
NCT06669351
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Start: Oct 31, 2024
Completion: Jul 15, 2025
NCT06841926
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
Start: Feb 20, 2025
Completion: Apr 18, 2025
NCT07095257
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
Start: Oct 20, 2025
Completion: Apr 15, 2026
Loading map...